MedPath

TIALIN-200 Medicated Premix Powder

Registration Number: MAL11110045HA

Approved
Approval ID

8b278dc5a4c84093

Registration Number

MAL11110045HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25.00 mcg/mLAvailable
Package Size: 25.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

TIAMULIN HYDROGEN FUMARATEActive
Monograph: tiamulin hydrogen fumarate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TIALIN-200 Medicated Premix Powder - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform